← Evidence map

ArticleTargeted oncology2024

Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis".

Brigida Anna Maiorano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis". | OpenQuestion